118 completed. 118 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 118 | Completed 118 |
Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of 0.75% Piroctone Olamine Shampoo on the Hair and Scalp Microbiota of Hijab-Wearing Women With Seborrheic Dermatitis in Indonesia Piroctone Olamine 0.75% Shampoo, Ketoconazole Shampoo, 2% - Seborrheic Dermatitis | Phase 4 | Completed | Universitas Indonesia | 86 | 2026-01-12 | 2026-09-03 |
| Topical Terbinafine Versus Hydrocortisone Combined With Oral Itraconazole for Seborrheic Dermatitis Itraconazole, Terbinafine 1% cream, Hydrocortisone 1% cream - Seborrheic Dermatitis | Phase 4 | Completed | Can Tho University of Medicine and Pharmacy | 76 | 2025-07-07 | 2026-10-30 |
| A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden Lebrikizumab - Atopic Dermatitis | Phase 4 | Completed | Eli Lilly and Company | 233 | 2025-06-16 | 2026-10-15 |
| Skin Barrier Function and Inflammation in Aging: The BIA Study CeraVe Moisturizing Cream, Vaseline - Inflammation, Skin Inflammation | Phase 4 | Completed | University of California, San Francisco | 32 | 2025-02-06 | 2026-07-14 |
| A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash "Cetaphil Healing Ointment" - Diaper Rash | Phase 4 | Completed | Galderma R&D | 26 | 2023-08-25 | 2026-05-12 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis Seysara Oral Product - Perioral Dermatitis | Phase 4 | Completed | The Dermatology Institute of Boston | 9 | 2023-07-17 | 2024-06-21 |
| Aquacel Hypersensitivity Dressing in TJAs Aquacel dressing - Contact Allergic Dermatitis, Adverse Skin Reaction | Phase 4 | Completed | Rush University Medical Center | 457 | 2023-06-18 | 2026-08-04 |
| A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis Upadacitinib - Atopic Dermatitis | Phase 4 | Completed | AbbVie | 461 | 2023-05-29 | 2025-07-29 |
| Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis Triamcinolone Acetonide (Aristocort® C), Vehicle - Atopic Dermatitis | Phase 4 | Completed | Innovaderm Research Inc. | 20 | 2023-05-09 | 2025-03-26 |
| Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis Dupilumab step-down - Atopic Dermatitis, Eczema, Atopic | Phase 4 | Completed | Nantes University Hospital | 256 | 2023-03-08 | 2026-09-24 |
| Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China Dupilumab - Atopic Dermatitis | Phase 4 | Completed | Sanofi | 34 | 2023-02-22 | 2025-02-10 |
| Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial dupilumab, Topical emollient (moisturizer) - Moderate-to-Severe Atopic Dermatitis, Atopic Eczema | Phase 4 | Completed | Regeneron Pharmaceuticals | 124 | 2023-01-11 | 2026-05-27 |
| Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab Abrocitinib - Atopic Dermatitis | Phase 4 | Completed | Innovaderm Research Inc. | 24 | 2022-11-25 | 2025-03-28 |
| Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China Dupilumab - Atopic Dermatitis, Dermatitis Atopic | Phase 4 | Completed | Sanofi | 44 | 2022-11-25 | 2025-09-15 |
| Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis Dupilumab, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide - Atopic Dermatitis | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 433 | 2022-11-21 | 2026-06-04 |
| Tacrolimus Versus Hydrocortisone in Atopic Dermatitis Tacrolimus, Hydrocortisone - Atopic, Dermatitis | Phase 4 | Completed | Ain Shams University | 200 | 2022-05-15 | 2023-07-24 |
| Effects of Tildrakizumab on Epigenetic Age TILDRAKIZUMAB - Psoriasis, Aging | Phase 4 | Completed | Carlos Wambier | 30 | 2022-04-08 | 2024-07-18 |
| Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients Olive oil cream, Betamethasone Valerate Cream, Base Cream - Radiodermatitis; Acute | Phase 4 | Completed | Cairo University | 132 | 2021-11-04 | 2025-02-12 |
| Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit Colloidal oatmeal, Cold cream - Diaper Rash, Preterm Neonates | Phase 4 | Completed | Seham El-Sayed Saleh Hassan | 90 | 2021-08-20 | 2023-09-22 |
| Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis Dupilumab (SAR231893) - Dermatitis Atopic | Phase 4 | Completed | Sanofi | 54 | 2021-04-22 | 2025-09-16 |
Showing 20 of 118. Sign in to see all of them.
Dermatitis, Atopic (87) · Eczema (19) · Dermatitis, Seborrheic (6) · Diaper Rash (5) · Psoriasis (5) · Pruritus (4) · Dermatitis, Allergic Contact (3) · Tinea Cruris (3) · Tinea Pedis (3) · Asthma (2) · Bronchiolitis Obliterans Syndrome (2) · Facies (2) · Inflammation (2) · Lymphoma, Follicular (2)
Skin and Connective Tissue Diseases (118) · Skin Diseases (117) · Skin Diseases, Eczematous (107) · Immune System Diseases (93) · Hypersensitivity (92) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (87) · Genetic Diseases, Inborn (87) · Hypersensitivity, Immediate (87) · Skin Diseases, Genetic (87) · Pathological Conditions, Signs and Symptoms (12) · Skin Diseases, Papulosquamous (12) · Dermatitis, Contact (7) · Sebaceous Gland Diseases (7) · Signs and Symptoms (7)
pimecrolimus (18) · Tacrolimus (12) · dupilumab (11) · crisaborole (5) · Petrolatum (4) · Adrenal Cortex Hormones (3) · Hydrocortisone (3) · Omalizumab (3) · montelukast (3) · Fluocinonide (2) · Fluticasone (2) · Saline Solution (2) · Sodium Chloride (2) · Triamcinolone Acetonide (2) · methylprednisolone aceponate (2)
Novartis (10) · Astellas Pharma Inc (7) · Sanofi (6) · Stiefel, a GSK Company (4) · Derm Research, PLLC (3) · Innovaderm Research Inc. (3) · University of California, San Francisco (3) · Wake Forest University (3) · Wake Forest University Health Sciences (3) · Allerderm (2) · Bayer (2) · Casa Espirita Terra de Ismael (2) · Ceragenix Pharmaceuticals (2) · Fougera Pharmaceuticals Inc. (2) · Janssen-Cilag Ltd.,Thailand (2)
United States (62) · Germany (9) · Canada (8) · United Kingdom (6) · Brazil (5) · Australia (4) · China (4) · France (4) · Switzerland (4) · Belgium (3) · Dominican Republic (3) · Egypt (3) · Finland (3) · Spain (3) · Vietnam (3)
Robert Bissonnette, MD (3) · Alan Fleischer, MD (2) · Anya Loncaric (2) · Leon H. Kircik, M.D. (2)
PMID 19127072, PMID 19403473, PMID 19863501, PMID 21099191, PMID 21121981, PMID 21533301, PMID 22134563, PMID 23377341, PMID 23388687, PMID 23545917, PMID 23675632, PMID 24435467, PMID 28330497, PMID 28491950, PMID 31764962, PMID 32212104, PMID 33760691, PMID 36824052, PMID 37181420, PMID 37799965, PMID 40973558, PMID 41350756, PMID 41611123, PMID 42027418, PMID 42126851, PMID 42617697
2004 (1), 2018 (1), R21AR082620 (1)